CGEM
Price
$17.67
Change
+$0.37 (+2.14%)
Updated
Jun 23, 04:04 PM (EDT)
Capitalization
1.06B
44 days until earnings call
Intraday BUY SELL Signals
IMMX
Price
$9.79
Change
+$0.40 (+4.26%)
Updated
Jun 23, 04:11 PM (EDT)
Capitalization
669.54M
71 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

CGEM vs IMMX

CGEM vs IMMX Comparison Chart in %
loading
loading
View a ticker or compare two or three
VS
CGEM vs. IMMX commentary
Jun 23, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CGEM is a Buy and IMMX is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 23, 2026
Stock price -- (CGEM: $17.30 vs. IMMX: $9.40)
Brand notoriety: CGEM and IMMX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CGEM: 134% vs. IMMX: 104%
Market capitalization -- CGEM: $1.06B vs. IMMX: $669.54M
CGEM [@Biotechnology] is valued at $1.06B. IMMX’s [@Biotechnology] market capitalization is $669.54M. The market cap for tickers in the [@Biotechnology] industry ranges from $118.47B to $0. The average market capitalization across the [@Biotechnology] industry is $2B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CGEM’s FA Score shows that 1 FA rating(s) are green whileIMMX’s FA Score has 0 green FA rating(s).

  • CGEM’s FA Score: 1 green, 4 red.
  • IMMX’s FA Score: 0 green, 5 red.
According to our system of comparison, CGEM is a better buy in the long-term than IMMX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CGEM’s TA Score shows that 5 TA indicator(s) are bullish while IMMX’s TA Score has 4 bullish TA indicator(s).

  • CGEM’s TA Score: 5 bullish, 5 bearish.
  • IMMX’s TA Score: 4 bullish, 5 bearish.
According to our system of comparison, CGEM is a better buy in the short-term than IMMX.

Price Growth

CGEM (@Biotechnology) experienced а +27.11% price change this week, while IMMX (@Biotechnology) price change was +11.04% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +5.89%. For the same industry, the average monthly price growth was +2.09%, and the average quarterly price growth was +1952.22%.

Reported Earning Dates

CGEM is expected to report earnings on Aug 06, 2026.

IMMX is expected to report earnings on Sep 02, 2026.

Industries' Descriptions

@Biotechnology (+5.89% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
CGEM($1.06B) has a higher market cap than IMMX($670M). IMMX YTD gains are higher at: 79.828 vs. CGEM (67.150). IMMX has higher annual earnings (EBITDA): -35.64M vs. CGEM (-240.04M). CGEM has more cash in the bank: 352M vs. IMMX (90.6M). IMMX has less debt than CGEM: IMMX (1.04M) vs CGEM (2.38M). CGEM (0) and IMMX (0) have equivalent revenues.
CGEMIMMXCGEM / IMMX
Capitalization1.06B670M159%
EBITDA-240.04M-35.64M673%
Gain YTD67.15079.82884%
P/E RatioN/AN/A-
Revenue00-
Total Cash352M90.6M389%
Total Debt2.38M1.04M230%
TECHNICAL ANALYSIS
Technical Analysis
CGEMIMMX
RSI
ODDS (%)
Bearish Trend 2 days ago
88%
N/A
Stochastic
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
87%
Momentum
ODDS (%)
Bullish Trend 2 days ago
73%
Bullish Trend 2 days ago
88%
MACD
ODDS (%)
Bullish Trend 2 days ago
82%
Bullish Trend 2 days ago
90%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
77%
Bullish Trend 2 days ago
88%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
75%
Bullish Trend 2 days ago
89%
Advances
ODDS (%)
Bullish Trend 2 days ago
75%
Bullish Trend 8 days ago
86%
Declines
ODDS (%)
Bearish Trend 8 days ago
87%
Bearish Trend 16 days ago
89%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
79%
Bearish Trend 2 days ago
90%
Aroon
ODDS (%)
Bullish Trend 2 days ago
79%
Bearish Trend 2 days ago
88%
View a ticker or compare two or three
Interact to see
Advertisement
CGEM
Daily Signal:
Gain/Loss:
IMMX
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
SPICX74.72N/A
N/A
Invesco S&P 500 Index C
NSOPX19.93N/A
N/A
North Star Opportunity A
SMRPX12.11N/A
N/A
Westwood Salient MLP & Engy Infras Ultr
HGASX28.80N/A
N/A
Hennessy Gas Utility Institutional
CWIFX81.69-0.05
-0.06%
American Funds Capital World Gr&Inc 529F

CGEM and

Correlation & Price change

A.I.dvisor indicates that over the last year, CGEM has been loosely correlated with VIR. These tickers have moved in lockstep 49% of the time. This A.I.-generated data suggests there is some statistical probability that if CGEM jumps, then VIR could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CGEM
1D Price
Change %
CGEM100%
+15.10%
VIR - CGEM
49%
Loosely correlated
+4.48%
PCVX - CGEM
44%
Loosely correlated
+1.30%
NRIX - CGEM
44%
Loosely correlated
+6.27%
RLAY - CGEM
43%
Loosely correlated
+8.82%
XNCR - CGEM
43%
Loosely correlated
+10.84%
More